Navigation Links
Scientists Uncover New Weapon Against Huntington's
Date:4/3/2009

Treatment could save brain cells from ravages of neurodegenerative disease

FRIDAY, April 3 (HealthDay News) -- Harvard scientists say they've found a possible way to prevent brain cells from falling victim to the ravages of Huntington's disease.

The work is still in the preliminary stages, and the researchers don't know if the strategy will work in humans. Still, a Huntington's disease expert said the findings could lead to a way to combat the incurable condition.

"They suggest a new way that you could approach developing treatments. I think it's going to emerge as a theme," said University of California at Irvine professor Leslie Thompson.

Huntington's disease is inherited, and children of parents with a single faulty gene have at least a 50 percent chance of developing it. The condition typically develops in middle age, causing the body to move involuntarily, leading to symptoms such as balance and coordination problems, slurred speech, swallowing problems and dementia.

Death typically occurs within 10 to 30 years.

There's no treatment to stop the progression of Huntington's disease or cure it, although patients can take drugs to control their symptoms.

"It's like when you have a rotten tooth," said study co-author Dr. Dimitri Krainc. "You can take painkillers so you don't feel the pain, but the tooth is still rotten."

Krainc, an associate professor of neurology at Harvard Medical School, and his colleagues tried to find a way to reduce the build-up of proteins in brain cells stricken by the disease.

Essentially, Krainc said, proteins pile up in the cells and cause problems. "It's like trash that doesn't get picked up in a crowded apartment," he said, "If you don't remove trash, it eventually suffocates you."

Indeed, clogged cells either stop functioning properly or die, Thompson said.

In the new study, the researchers tinkered with the troublesome proteins through genetic modification. They report their findings in the April 3 issue of Cell.

According to Krainc, the researchers found that their approach allowed proteins within the cells to degrade as they're supposed to. The strategy worked in worms, mice and the brain cells taken from dead people.

Drugs known as HDAC inhibitors have the same effect and are already being tested as treatments for Huntington's disease and cancer, Krainc said. The drugs are currently used to treat psychiatric disorders.

There are many unknowns, however. Researchers don't know whether the treatment will work in humans, and the potential costs of drugs are unclear.

Still, research may take a matter of years, not decades, Krainc said.

In the big picture, the new research "could have broad implications for a number of neurodegenerative diseases," Thompson said.

Alzheimer's disease, for example, is also caused when cells become clogged and fail to function properly.

"It's an extremely exciting and promising area of research," Thompson said, "and new and novel."

More information

To learn more about Huntington's disease, try the U.S. National Institutes of Health.



SOURCES: Dimitri Krainc, M.D., Ph.D., professor, neurology, Harvard Medical School, Boston; Leslie Thompson, Ph.D., professor, psychiatry and human behavior, University of California at Irvine; April 3, 2009, Cell


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Uncover New Weapon Against Huntington's
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under Dr. ... board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), a ... and delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding efforts ... hospital and decide to donate. , “Women’s Hospital at Renaissance has been a ...
(Date:4/28/2017)... Yorba Linda, Ca (PRWEB) , ... April 28, ... ... entities with cardiac or hERG liability could substantially improve drug safety and minimize ... will be provided for validating ion channel inhibition using cell lines and for ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ... ... valued at US$ 7,167.6 Mn in 2015, and is expected ... CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
Breaking Medicine Technology: